These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 17416007)

  • 41. Transarterial chemoembolization using degradable starch microspheres and iodized oil in the treatment of advanced hepatocellular carcinoma: evaluation of tumor response, toxicity, and survival.
    Kirchhoff TD; Bleck JS; Dettmer A; Chavan A; Rosenthal H; Merkesdal S; Frericks B; Zender L; Malek NP; Greten TF; Kubicka S; Manns MP; Galanski M
    Hepatobiliary Pancreat Dis Int; 2007 Jun; 6(3):259-66. PubMed ID: 17548248
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.
    Marelli L; Shusang V; Buscombe JR; Cholongitas E; Stigliano R; Davies N; Tibballs J; Patch D; Meyer T; Burroughs AK
    J Nucl Med; 2009 Jun; 50(6):871-7. PubMed ID: 19443599
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased expression of vascular endothelial growth factor in hepatocellular carcinoma after transcatheter arterial chemoembolization.
    Wang B; Xu H; Gao ZQ; Ning HF; Sun YQ; Cao GW
    Acta Radiol; 2008 Jun; 49(5):523-9. PubMed ID: 18568538
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combination therapy (intratympanic dexamethasone + high-dose prednisone taper) for the treatment of idiopathic sudden sensorineural hearing loss.
    Battaglia A; Burchette R; Cueva R
    Otol Neurotol; 2008 Jun; 29(4):453-60. PubMed ID: 18401285
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Meta-analysis of the efficacy of transcatheter arterial chemoembolization combined with percutaneous ethanol injection in treating unresectable primary liver cancer].
    Gu GW; Li XC
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(12):805-9. PubMed ID: 19595117
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transcatheter chemoembolization in the treatment of HCC in patients not eligible for curative treatments: midterm results of doxorubicin-loaded DC bead.
    Malagari K; Alexopoulou E; Chatzimichail K; Hall B; Koskinas J; Ryan S; Gallardo E; Kelekis A; Gouliamos A; Kelekis D
    Abdom Imaging; 2008; 33(5):512-9. PubMed ID: 17938995
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preoperative chemoembolization in patients with hepatocellular carcinoma undergoing liver transplantation: influence of emergent versus elective procedures on patient survival and tumor recurrence rate.
    Stockland AH; Walser EM; Paz-Fumagalli R; McKinney JM; May GR
    Cardiovasc Intervent Radiol; 2007; 30(5):888-93. PubMed ID: 17619218
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The significance of combined treatment for hepatocellular carcinoma with partial splenic embolization and transcatheter arterial chemoembolization using IA call/lipiodol].
    Harao M; Beppu T; Masuda T; Hayashi H; Okabe H; Okabe K; Imseung C; Komori H; Horino K; Baba H
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2027-9. PubMed ID: 19106512
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A nutrient mixture prevents acetaminophen hepatic and renal toxicity in ICR mice.
    Roomi MW; Kalinovsky T; Ivanov V; Rath M; Niedzwiecki A
    Hum Exp Toxicol; 2008 Mar; 27(3):223-30. PubMed ID: 18650254
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Iodized oil embolization to brain following transcatheter arterial embolization of liver.
    Wu RH; Tzeng WS; Chang CM
    J Gastroenterol Hepatol; 2005 Sep; 20(9):1465-7. PubMed ID: 16105143
    [No Abstract]   [Full Text] [Related]  

  • 51. [Dose finding of epirubicin in transcatheter hepatic chemoembolization].
    Nakamura H; Murakami T; Mitani T; Nakanishi K; Hori S; Kozuka T; Tsukaguchi I; Oi H; Matsushita M; Hosoki T
    Gan To Kagaku Ryoho; 1992 Nov; 19(13):2271-4. PubMed ID: 1332628
    [No Abstract]   [Full Text] [Related]  

  • 52. Multicentre randomised phase III trial comparing Tamoxifen alone or with Transarterial Lipiodol Chemoembolisation for unresectable hepatocellular carcinoma in cirrhotic patients (Fédération Francophone de Cancérologie Digestive 9402).
    Doffoël M; Bonnetain F; Bouché O; Vetter D; Abergel A; Fratté S; Grangé JD; Stremsdoerfer N; Blanchi A; Bronowicki JP; Caroli-Bosc FX; Causse X; Masskouri F; Rougier P; Bedenne L;
    Eur J Cancer; 2008 Mar; 44(4):528-38. PubMed ID: 18242076
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MR imaging perfusion mismatch: a technique to verify successful targeting of liver tumors during transcatheter arterial chemoembolization.
    Lewandowski RJ; Tepper J; Wang D; Ibrahim S; Miller FH; Kulik L; Mulcahy M; Ryu RK; Sato K; Larson AC; Salem R; Omary RA
    J Vasc Interv Radiol; 2008 May; 19(5):698-705. PubMed ID: 18440458
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of transcatheter arterial chemoembolization on CYP1A2 activity in patients with hepatocellular carcinoma.
    Huang W; Qu ZQ; Li XD; He P; Ding N; Zhang SL; Wu MC
    J Clin Pharm Ther; 2008 Oct; 33(5):489-93. PubMed ID: 18834363
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of salvia miltiorrhizae on apoptosis and NF-kappaB p65 expression in the liver of rats with severe acute pancreatitis or obstructive jaundice.
    Zhang X; Chen L; Zhang J; Tian H; Zhang X; Zhou Y; Wang Z; Wang K
    J Gastroenterol Hepatol; 2009 May; 24(5):841-52. PubMed ID: 19067778
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transarterial chemoembolization for primary hepatocellular carcinoma in patients at high risk.
    Kothary N; Weintraub JL; Susman J; Rundback JH
    J Vasc Interv Radiol; 2007 Dec; 18(12):1517-26; quiz 1527. PubMed ID: 18057286
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinico-roentogenologic findings in hepatocellular carcinoma fed by the right inferior phrenic artery at the initial chemoembolization.
    Kimura S; Okazaki M; Higashihara H; Haruno M; Nozaki Y; Urakawa H; Kora S; Shinagawa Y; Nonokuma M
    Hepatogastroenterology; 2009; 56(89):191-8. PubMed ID: 19453056
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Antimotion sickness effects of ginsenosides combined with dexamethasone in rats].
    Jia L; Wang WY; Zhou LM; Mo FF; Li M
    Zhong Xi Yi Jie He Xue Bao; 2010 Apr; 8(4):358-62. PubMed ID: 20388477
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chemoembolization combined with pravastatin improves survival in patients with hepatocellular carcinoma.
    Graf H; Jüngst C; Straub G; Dogan S; Hoffmann RT; Jakobs T; Reiser M; Waggershauser T; Helmberger T; Walter A; Walli A; Seidel D; Goke B; Jüngst D
    Digestion; 2008; 78(1):34-8. PubMed ID: 18797167
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biochemical and histopathological findings of N-butyl-2-cyanoacrylate in oral surgery: an experimental study.
    Inal S; Yilmaz N; Nisbet C; Güvenç T
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Dec; 102(6):e14-7. PubMed ID: 17138158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.